Conversion of Ginsenoside Rb1 into Six Types of Highly Bioactive Ginsenoside Rg3 and Its Derivatives by FeCl3 Catalysis

• Published in: Chemical and Pharmaceutical Bulletin Vol. 66; no. 9; pp. 901 - 906
• Main Authors: Hongshan Yua, Yu Wanga, Chunying Liub, Jiamei Yanga, Longquan Xua, Guanheng Lia, Jianguo Songa, Fengxie Jina
• Format: Journal Article
• Language: Japanese
• Published: Pharmaceutical Society of Japan 01.09.2018
• ISSN: 0009-2363; 1347-5223

Ginsenoside Rb1 is an important saponin of ginseng(s) ; however, Rb1, with 3-O- and 20-O-sugar moieties, has low bioavailability. Here, we report the derivatization of ginsenoside Rb1 to completely generate six types of highly bioactive minor ginsenoside Rg3 and its derivatives by FeCl3 catalysis, the reaction conditions are similar to enzymatic reaction conditions. In FeCl3 catalysis, the only 20-O-sugar-moiety of ginsenoside Rb1 was decomposed into the minor ginsenosides Rk1 and Rg5 with newly produced C-20 ethylene bands ; but also hydrolyzed into 20(S)-Rg3 and 20(R)-Rg3 ; subsequently the C-24(25) ethylene bands of 20(S)-Rg3 and 20(R)-Rg3 were hydrated to 20(S)-25-OH-Rg3 and 20(R)-25-OH-Rg3. After separation of reaction mixture from 34g ginsenoside-Rb1 by silica-gel-column, the 3.3g sample I of TLC top-band consisting of Rg5 and Rk1, 8.7g sample II of TLC middle-band consisting of 20(S)-Rg3 and 20(R)-Rg3, 3.5g sample III of TLC bottom-band consisting of unknown product-I and -II including 20(S)-25-OH-Rg3, were obtained. The sample III consisting of unknown product-I and -II was purified by crystallization, and identified to 20(S)-25-OH-Rg3 and 20(R)-25-OH-Rg3 by HPLC-Evaporative Light Scattering Detector (ELSD) and NMR. Therefore, six types of minor-ginsenosides Rk1, Rg5, 20(S)-Rg3, 20(R)-Rg3, 20(S)-25-OH-Rg3 and 20(R)-25-OH-Rg3 were successfully prepared from ginsenoside Rb1 by FeCl3 catalysis. FeCl3 has low toxicity and is inexpensive, and the reaction conditions are similar to enzymatic reaction conditions ; thus, this method is applicable to the development of ginseng-based drugs.